Basic Information
Basic information for LINC01814-203-109aa
Peptide Name LINC01814-203-109aa
Genome Position chr2:8576911-8577084,8578570-8578711,8580037-8580047[-]
Species Human
Peptide Sequence MGSRCYRITLTTLWDLWPCVHNSSHYRCFLNSCREPLSAPSHRSSQQPTRKLHREADATQATHPDAEPDSLRGLDGSFPAGVLSAKLPVTWGWRCSRESWPPLEEVTCG
Peptide Length 109
Unique No (LINC01814-205-109aa,LINC01814-207-109aa,LINC01814-209-109aa,LINC01814-210-109aa,LINC01814-212-109aa)
Grand Average of Hydropathicity -0.6248
Relative Molecular Mass 14238.62
Experimental Evidences 2:lncORF,ribo
lncRNA ID/Name ENSG00000236008;LINC01814
Transcript ID/Name ENST00000454224;LINC01814-203
Transcript Length 8839
Coding Ability 0.4814
DNA Sequence Corresponding to Peptide ATGGGCTCCAGGTGCTACCGGATCACCCTAACAACCCTCTGGGACCTGTGGCCATGTGTTCACAACAGCAGCCATTACAGGTGTTTCCTGAACTCTTGTCGCGAGCCTCTGTCGGCTCCATCTCATCGATCCTCCCAGCAACCCACAAGGAAGCTTCACAGAGAGGCAGATGCCACACAGGCCACCCACCCAGATGCAGAGCCAGATTCCCTGCGTGGACTGGACGGGAGTTTCCCAGCTGGAGTTCTCTCGGCCAAGCTGCCTGTGACATGGGGTTGGAGGTGCTCCAGAGAGTCATGGCCACCCCTGGAGGAAGTGACTTGTGGC
Experimental Evidences
   lncORF
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :